236 related articles for article (PubMed ID: 36163034)
21. Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: A pragmatic cluster randomized controlled trial study protocol.
Clouston K; Katz A; Martens PJ; Sisler J; Turner D; Lobchuk M; McClement S;
BMC Cancer; 2012 May; 12():182. PubMed ID: 22607726
[TBL] [Abstract][Full Text] [Related]
22. An electronic family health history tool to identify and manage patients at increased risk for colorectal cancer: protocol for a randomized controlled trial.
Goldstein KM; Fisher DA; Wu RR; Orlando LA; Coffman CJ; Grubber JM; Rakhra-Burris T; Wang V; Scheuner MT; Sperber N; Datta SK; Nelson RE; Strawbridge E; Provenzale D; Hauser ER; Voils CI
Trials; 2019 Oct; 20(1):576. PubMed ID: 31590688
[TBL] [Abstract][Full Text] [Related]
23. Protocol for population testing of an Internet-based Personalised Decision Support system for colorectal cancer screening.
Wilson CJ; Flight IH; Zajac IT; Turnbull D; Young GP; Cole SR; Gregory T
BMC Med Inform Decis Mak; 2010 Sep; 10():50. PubMed ID: 20843369
[TBL] [Abstract][Full Text] [Related]
24. Impact of a health literacy intervention combining general practitioner training and a consumer facing intervention to improve colorectal cancer screening in underserved areas: protocol for a multicentric cluster randomized controlled trial.
Durand MA; Lamouroux A; Redmond NM; Rotily M; Bourmaud A; Schott AM; Auger-Aubin I; Frachon A; Exbrayat C; Balamou C; Gimenez L; Grosclaude P; Moumjid N; Haesebaert J; Massy HD; Bardes J; Touzani R; Diant LBEF; Casanova C; Seitz JF; Mancini J; Delpierre C
BMC Public Health; 2021 Sep; 21(1):1684. PubMed ID: 34530800
[TBL] [Abstract][Full Text] [Related]
25. Developing an optimal stratification model for colorectal cancer screening and reducing racial disparities in multi-center population-based studies.
Tian J; Zhang M; Zhang F; Gao K; Lu Z; Cai Y; Chen C; Ning C; Li Y; Qian S; Bai H; Liu Y; Zhang H; Chen S; Li X; Wei Y; Li B; Zhu Y; Yang J; Jin M; Miao X; Chen K
Genome Med; 2024 Jun; 16(1):81. PubMed ID: 38872215
[TBL] [Abstract][Full Text] [Related]
26. A randomised controlled trial of personalised decision support delivered via the internet for bowel cancer screening with a faecal occult blood test: the effects of tailoring of messages according to social cognitive variables on participation.
Wilson CJ; Flight IH; Turnbull D; Gregory T; Cole SR; Young GP; Zajac IT
BMC Med Inform Decis Mak; 2015 Apr; 15():25. PubMed ID: 25886492
[TBL] [Abstract][Full Text] [Related]
27. Intervention to increase colorectal cancer screening among emergency department patients: results from a randomised pilot study.
Abar B; Park CS; Wood N; Marino D; Fiscella K; Adler D
Emerg Med J; 2024 Jun; 41(7):422-428. PubMed ID: 38777559
[TBL] [Abstract][Full Text] [Related]
28. Implementation of immunochemical faecal occult blood test in general practice: a study protocol using a cluster-randomised stepped-wedge design.
Juul JS; Bro F; Hornung N; Andersen BS; Laurberg S; Olesen F; Vedsted P
BMC Cancer; 2016 Jul; 16():445. PubMed ID: 27400657
[TBL] [Abstract][Full Text] [Related]
29. Assessing the effectiveness of a community health advisor plus screen to save educational intervention on stool-based testing adherence in an African American safety net clinic population: study protocol for a randomized pragmatic trial.
Luque JS; Matthew OO; Jackson DR; Vargas MA; Austin T; Ali A; Kiros GE; Harris CM; Tawk R; Gwede CK; Wallace K; Jean-Pierre P
Trials; 2022 Feb; 23(1):151. PubMed ID: 35168640
[TBL] [Abstract][Full Text] [Related]
30. Text Reminders in Colorectal Cancer Screening (TRICCS): Protocol for a randomised controlled trial.
Hirst Y; Kerrison R; Kobayashi LC; Counsell N; Djedovic N; Ruwende J; Stewart M; von Wagner C
BMC Public Health; 2016 Jan; 16():74. PubMed ID: 26809344
[TBL] [Abstract][Full Text] [Related]
31. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
32. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial.
Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S
Trials; 2012 Feb; 13():18. PubMed ID: 22348399
[TBL] [Abstract][Full Text] [Related]
33. Community Health workers United to Reduce Colorectal cancer and cardiovascular disease among people at Higher risk (CHURCH): study protocol for a randomized controlled trial.
Williams O; Ting T; Matthews L; Block G; Block T; Teresi J; Eimicke J; Kong J; Silver S; Ravenell J; Mallaiah J; Jammalamadaka S; Nelson LM; Karmally W; Hankerson S
Trials; 2024 Apr; 25(1):283. PubMed ID: 38671470
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of communication skills training on colorectal cancer screening by GPs: a cluster randomised controlled trial.
Aubin-Auger I; Laouénan C; Le Bel J; Mercier A; Baruch D; Lebeau JP; Youssefian A; Le Trung T; Peremans L; Van Royen P
Eur J Cancer Care (Engl); 2016 Jan; 25(1):18-26. PubMed ID: 25851842
[TBL] [Abstract][Full Text] [Related]
35. Computer-tailored intervention increases colorectal cancer screening among low-income African Americans in primary care: Results of a randomized trial.
Rawl SM; Christy SM; Perkins SM; Tong Y; Krier C; Wang HL; Huang AM; Laury E; Rhyant B; Lloyd F; Willis DR; Imperiale TF; Myers LJ; Springston J; Skinner CS; Champion VL
Prev Med; 2021 Apr; 145():106449. PubMed ID: 33549682
[TBL] [Abstract][Full Text] [Related]
36. Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial.
Goshgarian G; Sorourdi C; May FP; Vangala S; Meshkat S; Roh L; Han MA; Croymans DM
JAMA Netw Open; 2022 Feb; 5(2):e2146863. PubMed ID: 35119462
[TBL] [Abstract][Full Text] [Related]
37. Effect of a Digital Health Intervention on Receipt of Colorectal Cancer Screening in Vulnerable Patients: A Randomized Controlled Trial.
Miller DP; Denizard-Thompson N; Weaver KE; Case LD; Troyer JL; Spangler JG; Lawler D; Pignone MP
Ann Intern Med; 2018 Apr; 168(8):550-557. PubMed ID: 29532054
[TBL] [Abstract][Full Text] [Related]
38. Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios.
Dillon M; Flander L; Buchanan DD; Macrae FA; Emery JD; Winship IM; Boussioutas A; Giles GG; Hopper JL; Jenkins MA; Ait Ouakrim D
PLoS Med; 2018 Aug; 15(8):e1002630. PubMed ID: 30114221
[TBL] [Abstract][Full Text] [Related]
39. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
40. Increasing bowel cancer screening using SMS in general practice: the SMARTscreen cluster randomised trial.
McIntosh JG; Jenkins M; Wood A; Chondros P; Campbell T; Wenkart E; O'Reilly C; Dixon I; Toner J; Martinez-Gutierrez J; Govan L; Emery JD
Br J Gen Pract; 2024 Apr; 74(741):e275-e282. PubMed ID: 38164588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
